The impact of inflammation to the antioxidant defense parameters in AMD patients

Aging Clinical and Experimental Research

Volumn 24, Issue 6, 2012, Pages 588-594

  Čolak, Emina ^a   Majkić Singh, Nada ^a   Žorić, Lepša ^a   Radosavljević, Aleksandra ^a   Kosanović Jaković, Natalija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Age related macular degeneration; Antioxidants; Inflammation; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 6; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY;

AGED; AGING; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACULAR DEGENERATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84876919797     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/8593     Document Type: Article

References (30)

1. Čolak E. New markers of oxidative modifications to macromolecules. J Med Biochem 2008; 27: 1-16. (Pubitemid 351498895)
2. Coleman H, Chan CC, Ferris FL, Chew EY. Age-related macular degeneration. Lancet 2008; 372: 1835-45.
3. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006; 58: 353-63. (Pubitemid 44111070)
4. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Molecular Vision 1999; 5: 32-45.
5. Lange CAK, Bainbridge JWB. Oxygen sensing in retinal health and disease. Ophthalmologica 2012; 227: 115-31.
6. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of the aging. Proc Natl Acad Sci USA 1993; 90: 7915-22. (Pubitemid 23260825)
7. Nikolic-Kokic A, Blagojevic D, Spasic MB. Complexity of free radical metabolism in human erythrocytes. J Med Biochem 2010; 29: 189-95.
8. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005; 112: 2076-80. (Pubitemid 41720983)
9. Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol 2007; 125: 300-5. (Pubitemid 46425556)
10. Omoigui S. The interleukin-6 inflammation pathway from cholesterol to aging - Role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing 2007; 4: 1-28.
11. Seddon JM, George S, Rosner B, Rifai N. Progression of the age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6 and other cardiovascular biomarkers. Arch Ophthalmol 2005; 123: 774-82. (Pubitemid 41056598)
12. Goldstein S, Michel C, Boors A, Saran M, Czapsky G. A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Radical Biol Med 1988; 4: 295-303.
13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of glutathione peroxidase. J Lab Clin Med 1967; 70: 158-63.
14. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-12. (Pubitemid 23113948)
15. Goldberg DM, Spooner RJ. In Bergmeyer HU (Ed) Methods of enzymatic analysis, 3rd ed. New York: Academic Press; Vol 3, 1974: pp 258-65.
16. Wakamatsu TH, Dogru M, Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol 2008; 71 (Suppl) :72-9.
17. Yildirim Z, Uegun NI, Yildirim F. The role of oxidative stress and antioxidants in pathogenesis of age-related macular degeneration. Clinics 2011; 66: 743-6.
18. Imamura Y, Noda S, Hashizuma K et al. Drusen, choroidal neovascularization and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci USA 2006; 103: 11282-7. (Pubitemid 44156510)
19. Hübner-Woźniak E, Okecka-Szymańska J, Stupnicki R, Malara M, Kozdroń E. Age-related blood antioxidant capacity in men and women. J Med Biochem 2011; 30: 103-8.
20. Klouche M, Rose-John S, Schmiedt W, Bhakdi S. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000; 101: 1799-805. (Pubitemid 30213101)
21. Williams N, Bertoncello I, Jackson H, Arnold J, Kavnoudias H. The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production. Ciba Found Symp 1992; 167: 160-70.
22. Seino Y, Ikeda U, Ikeda M et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994; 6: 87-91. (Pubitemid 24120205)
23. Burstein SA. Effects of interleukin 6 on megakaryocytes and on canine platelet function. Stem Cells 1994; 12: 386-93. (Pubitemid 24243721)
24. Verma S, Badiwala MV, Weisel RD et al. C-reactive protein upregulates the NF-κB signaling pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg 2003; 126: 1886-91. (Pubitemid 38020747)
25. Čolak E, Kosanović-Jaković N, Žorić L, Radosavljević A, Stanković S, Majkić-Singh N. The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration. Ophthalmic Res 2011; 46: 125-32.
26. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-10. (Pubitemid 38543790)
27. Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW. C-Reactive Protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 2008; 49: 2053-60.
28. De Jong PT, Boekhoorn SS, Vingerling JR, Witteman JCM, Hofman A. C-reactive protein and incident aging macular disease (AMD): The Rotterdam Study. Invest Ophthalmol Vis Sci 2005; 46: E-Abstract 2379.
29. Kikuchi M, Nakamura M, Ishikawa K et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmol 2007; 114: 1722-7. (Pubitemid 47332667)
30. Boekhoom SS, Vingerling JR, Witteman JC, Hofman A, de Jong P. C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Arch Ophthalmol 2007; 125: 1396-401. (Pubitemid 47606607)